Showing 1 - 7 results of 7 for search '"direct-acting agents"', query time: 0.87s Refine Results
  1. 1
    Prisoners Treated for Hepatitis C with Protease Inhibitor, New York, USA, 2012

    Prisoners Treated for Hepatitis C with Protease Inhibitor, New York, USA, 2012 by Harish Moorjani, Carl Koenigsmann, Min Jung Kim, Anne C. Spaulding

    Published 2015-01-01
    Subjects:
    Get full text
    Article
  2. 2
    Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents

    Enhanced liver fibrosis score as a noninvasive biomarker in hepatitis C virus patients after direct-acting antiviral agents by Valentina Cossiga, Evelina La Civita, Dario Bruzzese, Maria Guarino, Andrea Fiorentino, Rosanna Sorrentino, Giuseppina Pontillo, Luca Vallefuoco, Stefano Brusa, Emma Montella, Daniela Terracciano, Filomena Morisco, Giuseppe Portella

    Published 2022-08-01
    Subjects:
    Get full text
    Article
  3. 3
    Cost-effectiveness of antiviral therapy in chronic hepatitis C (G1)

    Cost-effectiveness of antiviral therapy in chronic hepatitis C (G1) by A. V. Rudakova, D. A. Gusev, A. N. Uskov, Yu. V. Lobzin

    Published 2016-02-01
    Subjects:
    Get full text
    Article
  4. 4
    Evaluation of the effect of direct-acting antiviral agents on melatonin level and lipid peroxidation in chronic hepatitis C patients

    Evaluation of the effect of direct-acting antiviral agents on melatonin level and lipid peroxidation in chronic hepatitis C patients by Nageh Ahmed El-Mahdy, Sabry Abou-Saif, Medhat Ismail Abd EL hamid, Heba M. Hashem, Mohamed Anwar Hammad, Sally El-Sayed Abu-Risha

    Published 2023-08-01
    Subjects:
    Get full text
    Article
  5. 5
    Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis C Infection

    Effects of Achieving Sustained Virologic Response after Direct-Acting Antiviral Agents on Long-Term Liver Fibrosis in Diabetics vs. in Non-Diabetic Patients with Chronic Hepatitis... by Marian-Sorin Popescu, Dan-Mihai Firu, Vlad Pădureanu, Cristina Maria Mărginean, Radu Mitruț, Andreea Letitia Arsene, Dragoș Nicolae Mărgăritescu, Daniela Calina, Anca Oana Docea, Paul Mitruț

    Published 2022-08-01
    Subjects:
    Get full text
    Article
  6. 6
    Hyperbilirubinemia without Transaminitis during Combined Therapy with Daclatasvir and Asunaprevir

    Hyperbilirubinemia without Transaminitis during Combined Therapy with Daclatasvir and Asunaprevir by Hayato Baba, Kazuto Tajiri, Kohei Nagata, Kengo Kawai, Masami Minemura, Toshiro Sugiyama

    Published 2016-07-01
    Subjects:
    Get full text
    Article
  7. 7
    Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial

    Effect of vitamin D supplementation in patients with chronic hepatitis C after direct-acting antiviral treatment: a randomized, double-blind, placebo-controlled trial by Supachaya Sriphoosanaphan, Kessarin Thanapirom, Stephen J. Kerr, Sirinporn Suksawatamnuay, Panarat Thaimai, Sukanya Sittisomwong, Kanokwan Sonsiri, Nunthiya Srisoonthorn, Nicha Teeratorn, Natthaporn Tanpowpong, Bundit Chaopathomkul, Sombat Treeprasertsuk, Yong Poovorawan, Piyawat Komolmit

    Published 2021-02-01
    Subjects:
    Get full text
    Article

Search Tools: